Trials / Unknown
UnknownNCT02695979
Changes of Macrophage Migration Inhibitory Factor During Orthotopic Liver Transplantation
Changes of Macrophage Migration Inhibitory Factor and Thyroid Hormones During Liver Transplantation. Association With Graft Dysfunction
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Collecting blood, graft liver effluent and urine samples from patients undergoing orthotopic liver transplantation.
Detailed description
Aims are to measure Macrophage Migration Inhibitory Factor, Macrophage Migration Inhibitory Factor II and its' soluble receptor CD74 in serum, liver graft effluent and urine in and evaluate MIF's role in hepatic ischemia/reperfusion injury, postoperative graft function and kidney function.
Conditions
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2018-09-01
- Completion
- 2019-08-01
- First posted
- 2016-03-02
- Last updated
- 2018-03-01
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT02695979. Inclusion in this directory is not an endorsement.